DePaul Journal of Health Care Law
Volume 13
Issue 3 Summer 2011

Article 3

October 2015

Sleep Deprived Physicians Considering Modafinil: Using a
Controlled Substance for Cognitive Enhancement Gambles with
Differential Drug Responses and Violates Ethical and Legal Duties
Against Physician Impairment
Katherine Drabiak-Syed

Follow this and additional works at: https://via.library.depaul.edu/jhcl

Recommended Citation
Katherine Drabiak-Syed, Sleep Deprived Physicians Considering Modafinil: Using a Controlled Substance
for Cognitive Enhancement Gambles with Differential Drug Responses and Violates Ethical and Legal
Duties Against Physician Impairment, 13 DePaul J. Health Care L. 339 (2011)
Available at: https://via.library.depaul.edu/jhcl/vol13/iss3/3

This Article is brought to you for free and open access by the College of Law at Digital Commons@DePaul. It has
been accepted for inclusion in DePaul Journal of Health Care Law by an authorized editor of Digital
Commons@DePaul. For more information, please contact digitalservices@depaul.edu.

SLEEP DEPRIVED PHYSICIANS CONSIDERING
MODAFINIL:
USING A CONTROLLED SUBSTANCE FOR COGNITIVE
ENHANCEMENT GAMBLES WITH DIFFERENTIAL DRUG
RESPONSES AND VIOLATES ETHICAL AND LEGAL DUTIES
AGAINST PHYSICIAN IMPAIRMENT
By Katherine Drabiak-Syed*
I. INTRODUCTION
In several employment sectors, the human need for sleep has been
cast as an impediment to maximizing one's contribution to the
professional field and a barrier that should be minimized or overcome. To
achieve optimal productivity and push employees to perform for extended
hours, the military advocates the use of psychopharmacological cognitive
enhancement drugs (PCEDs) to enhance soldiers' vigilance and attention
to detail on extended missions. Section II will describe the military's
approach to cognitive enhancement and how scholars and physicians have
suggested that physicians should adopt the military's rationale for using
PCEDs to enhance mental acuity and alertness despite extreme
physiological and cognitive exhaustion. Section III will address the
endorsement for physician use of stimulant drugs such as modafinil as a
solution to physician fatigue, specifically during the period of medical
residency when physicians face long hours, overnight shifts, and
demanding schedules.
This section will also address how medical
culture's unwavering imposition of this rigorous schedule and imposed
sleep deprivation has neurological, cognitive, and physiological
consequences on the physician, the physician's ability to practice
medicine, and the quality of patient care. Section IV will explore why
modafinil constitutes an unpredictable and problematic drug for physicians
interacting with patients by providing an overview of the drug profile, how
it is regulated by the FDA and the Controlled Substances Act, and a
summary of research relating to the drug's intended and unexpected
* This publication was supported by a grant from the Richard M. Fairbanks Foundation to the IU Center for
Bioethics, and by NIHINCRR Grant Number RR025761. Its contents are solely the responsibility of the
author and do not necessarily represent the official views of the NIH.
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effects on subjects. Lastly, Section V will discuss how using modafinil
during a shift violates the physician's ethical and legal duties to refrain
from practicing medicine under the influence of non-medical drugs and
how practicing while impaired can expose the physician to professional
sanction or tort liability.
II. APPROACHING THE HUMAN NEED FOR SLEEP AS A
PROFESSIONAL IMPEDIMENT
Using modafinil to improve concentration, alertness, or forgo sleep is
classified as an enhancement because it constitutes "an intervention
designed to improve human form or functioning beyond what is necessary
to sustain or restore good health."' Rather than treating an existing illness
or condition, using a drug for performance enhancement or sleep
avoidance (PESA) constitutes an amplification or extension of human
limits. The pressure to forgo sleep while maintaining productivity has
been discussed as it relates specifically to two sectors of society: the
military and the medical profession.2 This section will discuss why and in
what circumstances the military sanctions the use of stimulants including
modafinil and how some physicians and scholars may use this logic as a
means to permit or promote physician use of modafinil.
A. Learning From The Military: Fatigue As Commodity
Few sectors of society openly endorse the use of stimulants for PESA
purposes. The military is one arena that directly promotes the use of
stimulants (and sedatives) for use in combat or in circumstances of
"operational necessity."' Operational necessity is defined as sustained or
continuous operations when the mission consists of twenty four hours or
longer to reach a common goal, where the soldier will encounter conflict
with circadian rhythm patterns, and experience symptoms of sleep
deprivation that interfere with the ability to perform on the mission.' Sleep
1. Reinoud de Jongh et al., Botox for the Brain: Enhancement of Cognition, Mood and Pro-Social
Behavior and Blunting of Unwanted Memories, 32 NEUROSCIENCE & BEHAVIORAL REVIEWS 760, 761
(2008).
2.

Veikko Launis, Cosmetic Neurology: Sliding Down the Slippery Slope? 19 CAMBRIDGE QUARTERLY

OF HEALTHCARE ETHICS317 (2010) (quoting Chatterjee on the obligation to extend one's self in social and
work environments).
3. JIM FRASER, PERFORMANCE MAINTENANCE DURING CONTINUOUS FLIGHT OPERATIONS, at 26,
available at http://www.public.navy.mil/navsafeen/Documents/aviation/operations/Performance
Maintenance.ppt.; see generally Catherine Annas & George Annas, Enhancing the Fighting Force:
Medical Research on American Soldiers, 25 J.OF CONTEMP. HEALTH L. & POL'Y 283 (2009).

4.

FRASER, supra note 3, at 5.
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deprivation increases the reaction time a soldier needs to respond to
stimuli, diminishes memory, reduces attention, and can affect mood.'
These normal responses to sleep deprivation interfere with the
performance goal for members of the military to sustain "optimal job
productivity with no or absolutely minimal adverse impact on safety,
health, and general well-being.6 Accordingly, the military classifies
fatigue as a commodity to be managed.' Counter-fatigue training declares
that all commanding officers and squadrons should adopt this philosophy
by utilizing a combination of stimulants and sedatives to achieve the
optimal productivity performance with minimal adverse impact on safety,
health and well-being.
By promulgating a goal for soldier performance that views the human
need for sleep as an impediment to job performance, the military creates a
problematic paradigm shift of what it means to sustain versus enhance
productivity and the expected abilities required to do one's job. Counterfatigue training specifically defines that providing a combination of timed
stimulants and sedatives constitutes performance maintenance, not
performance enhancement.9 Including extending and prolonging human
capabilities within the definition of maintenance is significant because it
shifts the perception of physiological and cognitive normalcy. Within this
framework, a soldier would take a stimulant to prevent the fatigue from
impairing the soldier's physiological and cognitive state. This paradigm
sets forth the proposition that soldiers should be able to perform
continuously for as long as necessary to achieve the goals of the mission
and that this does not constitute an enhancement.'"
However, this definition strategically excludes the reality that a
soldier's physiological and cognitive state are inherently tied to the
satisfaction of biological requirements such as water, food, and sleep.
When the normal curve of human capacity decreases after a certain
number of hours awake, interceding with this level of capability
necessarily constitutes an enhancement because it increases what the
soldier would otherwise be able to do." Re-defining this paradigm is

5. Id. at slide 11.
6. WARFIGHTER ENDURANCE MANAGEMENT DURING CONTINUOUS FLIGHT AND GROUND OPERATIONS:
AN AIR FORCE COUNTER FATIGUE GUIDE at 4, available at http://www.scribd.com/doc/1 512815/US-AirForce-WarfighterEnduranceManagement (hereinafter "Counter Fatigue Guide).
7. FRASER, supra note 3, at 19.
8.

See id. COUNTER FATIGUE GUIDE, supra note 6, at 4.

9. FRASER, supra note 3, at 26.
10. Annas & Annas, supranote 3, at 287.
11. FRASER, supra note 3, at 12.
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problematic and significant because it views baseline human capabilities
as a shortcoming and sleep as a barrier to a particular level of expected and
"necessary" performance.
B. Attention To Detail And Sustained Vigilance: The Military To
Civilian Transition
This drive to enhance baseline performance when it begins to
naturally decline can be an attractive proposition to individuals in other
professions in the civilian sector where fatigue also serves as a barrier to
mental acuity and alertness. As in the military, many other individuals
encounter career demands that are not constrained by a clock or the
individual's biological needs for sleep. 2 Several scholars have suggested
that the use of psychopharmacological cognitive enhancement drugs
(PCEDs) in the professional setting should not only be tolerated, but also
encouraged for professionals such as air-traffic controllers, surgeons, and
nurses who may work long shifts." An article in the Times out of the UK
proclaimed that everyone from judges, to cabinet ministers, to police, who
may have trouble staying awake could all present a more alert and
intelligent face to the world if they took modafinil.14
When an advisory panel for the FDA considered (and later rejected)
endorsing expanded product usage, an FDA official echoed this sentiment,
stating that it was "not completely obvious" that healthy people using
modafinil to stay alert would constitute a "bad thing" because sleepy
people can endanger others." Although the FDA declined to officially
expand acceptable uses for modafinil as a method to generally promote
wakefulness, this concept of using the drug to enhance performance has
been discussed as a possible solution to overcome mental and physical
fatigue arising from long and demanding professional schedules.
Indeed, numerous publications connect the professional demands of
select military operations to physician residents and surgeons (hereinafter
"physicians" or "residents") who may experience fatigue as a barrier to
mental acuity and alertness during sustained continuous work." Scholars
12. Simon Williams et al., Waking Up To Sleepiness: Modafinil, the Media, and the
Pharmaceuticalisationof Everyday/Night Life, 30 SOC. HEALTH & ILLNESS 839, 845 (2008).
13. Barbara Sahakian & Sharon Morein-Zamir, Professor's Little Helper, 450 NATURE 1157, 1158
(2007).
14. Williams et al., supra note 12, at 847.
15. Andrew Pollack & Alicia Ault. Advisory Panel Endorses More Uses for Stimulant, N.Y. TIMES,
Sept. 26, 2003.
16. See Anjan Chatterjee, Cosmetic Neurology: the Controversy Over EnhancingMovement, Mentation,
and Mood, 63 NEUROLOGY 968, 972 (2004); Steven Rose & Timothy Curry, In reply to: Fatigue
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have recently suggested that some proponents of psychopharmacological
enhancement will use similar rationale to justify expanded usage of
PCEDs such as modafinil into challenging professions within the civilian
sector." Similar to soldiers in the military, physicians also work in an
unpredictable (albeit vastly different) setting that requires attention to
detail and sustained vigilance for an extended period of time. " Continuity
of care for a particular patient, extended surgery, or long shift hours all
mean that the physician must be awake and functionally adept for physical
care such as handling a scalpel or performing complex cognitive
processing such as accurately diagnosing a mystery condition and
appropriately treating a patient. As in the military, an error in judgment
such as incorrectly diagnosing an emergency illness or a slip of the hand
during surgery can mean the difference between life and death for a
patient.
Recent literature boldly posits that physicians should not merely be
permitted to use PCEDs, but also affirmatively endorses that physicians
should use stimulants to enhance their physiological and cognitive
processing as it begins to decline as they become more fatigued." In the
March 2010 edition of Mayo Clinic Proceedings, Drs. Rose and Curry
declared that resident physicians have an ethical duty to reduce error
during periods of fatigue.20 Problematically, they argued this means
ingesting a stimulant for performance enhancement and sleep avoidance
during a shift when a resident physician is experiencing fatigue as the
more ethical choice than forgoing the stimulant.2 1 Similarly, Webb and
colleagues have also raised the issue of physician sleep deprivation, and
they characterize the problem of physician fatigue as a "state of
impairment" that poses a danger to patients and contributes to medical
errors. 22
However, Webb and colleagues channel this issue into
wondering why physicians are permitted to care for patients when they are
sleep deprived, when simply telling physicians to use PCEDs would

Countermeasures, and Performance Enhancement in Resident Physicians, 85 MAYO CLINIC PROC. 300,
301-302 (2010); Annas & Annas, supra note 3, at 292-300.
17. See Chatterjee, supra 16; A Ravelingien & A. Sandberg, Sleep Better Than Medicine? Ethical Issues
Related to "Wake Enhancement, " 34 J. OF MED. ETHICS 1,4 (2008).
18. See COUNTER FATIGUE GUIDE, supra note 6, at 7 (discussing how military work entails unpredictable
settings, attention to detail and vigilance).
19. Rose & Curry, supra note 16; see Jadon Webb et al., Contemplating Cognitive Enhancement in
Medical Students and Residents, 53 PERS. INBIOLOGY & MED. 200 (2010).
20. Rose & Curry, supra note 16.
21. Id.
22. Webb et al., supra note 19, at 207.
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minimize the "problem."23
This characterization reiterates the demands placed on physicians that
simply cannot be achieved within the confines of human biological needs
of restoration and sleep. Rather than focusing on the problem as
physicians' inability to maintain professional performance during long
shifts or without proper rest, we should shift the scrutiny to the problem of
the physician schedule, specifically during the period of medical residency
to better understand the demands placed on physicians.24
III. MEDICAL CULTURE'S HOSTILITY TOWARD SLEEP: TO
WHAT COST?
A. Medical Culture And Physician Schedule Demands
Long shifts, overnight on call periods, and demanding schedules have
been described as a necessary component of learning during physician
residency.2 5 In 2003, the Accreditation Council for Graduate Medical
Education (ACGME) set forth standards and limits on resident duty hours
and in 2010 it convened a task force to revise the standards. 26 The Task
Force on Quality Care and Professionalism promulgated its new
requirements in 2010, and the Common Program Requirements will be
effective July 1, 2011. According to the Common Program Requirements,
residents should not be scheduled for more than eighty hours per week as
averaged over a period of four weeks, continuous on site duty may not
exceed twenty-four hours (limited to sixteen hours for first year residents),
and residents should be provided a ten hour rest period between duty
hours.27
Despite these limits, the actual hours residents work may be
significantly higher for three reasons. First, individual programs may
apply for a ten percent increase in weekly duty hour limit, which could
increase the weekly limit to eighty eight hours.28 Second, the on site limit
23. Id.
24. See Jennifer Whetsell, Changing the Law, Changing the Culture: Rethinking the "Sleepy Resident"
Problem, 12 ANN. HEALTH L. 23 (2003) (discussing components of medical residency programs.)
25. Eleanor Stoller et al., Strategies Resident Physicians Use to Manage Sleep Loss and Fatigue,10 MED.
EDUC. ONLINE 1, 1 (2005).
26. Accreditation Council for Graduate Medical Education, ACGME Duty Hours, (2002), at:
http://www.acgme.org/acWebsite/dutyHours/dhindex.asp.
27. Accreditation Council for Graduate Medical Education, Common Program Requirements, (2007), at:
http://www.acgme.org/acWebsite/dutyHours/dh ComProgrRequirmentsDutyHours0707.pdf. (herein after
"Program Requirements").
28. Id.
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only refers to accepting new patients within that timeframe. 29 After the on
site limit, the standards provide for up to an additional six hours for
transfer of care and education activities.30 Lastly, the new standards
clarified that residents should be provided ten hours between periods of
duty, but only eight hours is actually required.3 '
Factoring in these additional guidelines, residents may still be
working well over one hundred hours a week. If the institution adopts a
schedule to maximize hours on duty, the amount of total hours residents
work per shift could range upwards from twenty to thirty hours for first
year residents and other residents, respectively.
This length of shifts means that residents may be required to skip
sleeping altogether at the time in the circadian rhythm when the body
should be sleeping.32 Both the length of schedule and the potential to
maximize duty hours means that residents may be required to report for a
shift and rest at vastly a different time at each subsequent shift. Varying
time on site and periods available for rest means residents are forced to
sleep at different hours of the twenty four hour day depending on when a
shift begins and ends. This scheduling conflicts with the human biological
circadian clock, which requires a full seven days to reset and adjust to a
new schedule."
Even if residents had time adjust to a different sleep wake pattern,
many residents may still not function well during the night periods based
on internal cues of circadian rhythm, which anticipate periods of activity
and rest even in the absence of lightness and darkness.3 4 During the times
when the body anticipates sleep but is on site working a shift, the resident
may experience drowsiness, fatigue, and the inability to perform activities
without falling asleep.
Furthermore, if a program provides residents eight hours between
periods of duty, this still does not allow for sufficient time for the resident
to sleep eight hours after factoring in other activities such as traveling to
and from work, finding time to eat, exercise, engage in social time with
family or friends, or perform any other life activity. Sleeping less than
29.
30.
31.

Id.
Id.
Id.

32.

FRASER, supra note 3, at 13.

33. Id. at 8; see also Robert Bird & Niki Mirtorabi, Shifiwork and the Law, 27 BERKELEY J. EMP. & LAB.
L. 383, 389-390 (2006) (discussing how the circadian rhythm affects sleep and wake times and how
adjusting the circadian rhythm disrupts the ability to sleep and the quality of sleep).
34. Bird & Mirtorabi, supranote 33, at 389.
35. Id. at 390.
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eight hours has a marked effect on vigilance, and continually sleeping less
than eight hours means that the residents' alertness and performance will
deteriorate further over time.16 Lastly, disrupting time available for sleep
and scheduling sleep without regard for circadian rhythm patterns means
that if the physician can and does fall asleep during the rest period, this
sleep may be brief, fitful, and insufficiently restorative.
The length of shift, rotation in shift times, and lack of rest between
shifts means residents may have neither sufficient time to sleep and the
time permitted may not correspond to biologically set periods that the
resident needs sleep or can fall and stay asleep. In sum, the Common
Program Requirements fail to sufficiently address how to accommodate
residents' biological need for sleep. 38
Some physicians and educators demonstrate striking resistance to
reforming resident work hours, arising from medical culture's focus on
service, sacrifice, and indoctrination.39 Medical culture instills a belief that
long hours are necessary to teach residents the rigors of the profession,
instill a sense of selflessness, and encourage commitment to patient care.40
Residents who voice concerns relating to the demanding schedule or
register their need for more sleep may be dismissed as weak or whining
without meritorious reason.4' Physician residents may believe sleep loss
constitutes an honored feature of residency training that they can
overcome once they complete the residency program.42
Despite these potentially obscene schedules, some physicians who
train residents insist these hours are a necessary component of medical
training. 43 These physicians maintain that residents must learn how to
function effectively despite fatigue, or that sleep deprivation constitutes a
rite of passage to the medical profession.44 Still other physicians refute
that sleep deprivation even constitutes a problem and assert no studies
show a connection between resident fatigue and medical errors.45 Despite
36.

Fraser, supra note 3, at 12, 15.

37. Bird & Mirtorabi, supra note 33, at 390.
38. See Whetsell, supra note 24, at 30 (some critics refer to residents' schedule as similar to working in a
sweatshop).
39. David Villar Patton et al., Legal Considerationof Sleep Deprivation Among Resident Physicians, 34
JOURNAL OF HEALTH LAW 377, [12] (2001).

40. Id.
41. Merit Buckley, Imposing Liability in the United States Medical Residency Program: Exhaustion,
Errors, and Economic Dependence, 12 DEPAUL J. HEALTH CARE L. 305, 315 (2009); Whetsell, supra note

24, at 46.
42. Stoller et al., supra note 25, at 9.
43. Whetsell, supranote 24, at 45-46.
44. Id
45. Buckley, supra note 41.
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these denials, research confirms that residents schedules do not allow for
sufficient sleep, which negatively impacts both the physician and the
patients under the care of the physician.4 6

B. Sleep Loss And Effect On The Physician
Sleep loss has enormous consequences for the physician's
neurological, cognitive, and physiological state. To understand how to
frame this problem, it is imperative to reiterate that these ill health effects
do not arise from an independent existing condition or disease, but that
they are a direct manifestation of restricting sleep. Since the introduction
of shift work sleep disorder (SWSD), the line between what constitutes a
disease and what constitutes a normal human response to external
restrictive conditions has become increasingly blurred. 47 For physicians,
experiencing cognitive and physiological fatigue becomes characterized
according to medical culture- that physicians experience ill health effects
from individual pathology, of not being "tough enough" to handle a
rigorous schedule rather than acknowledging that the schedule itself
directly contributes to ill health effects. As one commentator noted, this
48
framework turns into trying to treat the human need for sleep.
Pathologizing the human need for sleep ignores that sleep is a
49
Sleep loss
biological necessity that neither can, nor should, be "cured."
produces negative and cumulative effects on in the individual over time,
resulting in a sleep debt." Lack of sleep affects physicians across multiple
dimensions, in both personal and professional settings." Forgoing sleep
for a night produces neurological and physiological effects similar to
intoxication, degrading mental and motor skill performance.52 In the
professional arena, physicians who are sleep deprived have decreased
cognitive ability and a negative impact on professionalism, task

46. See generally Whetsell, supra note 24; Buckley, supra note 41; Patton et al., supra note 39.
47. Webb et al., supra note 19, at 205 (discussing FDA approval of modafinil for SWSD). A full
discussion of medicalization and whether SWSD should constitute a condition is outside the scope of this
article.
48. Anahad O'Connor, Wakefidness Finds a Powerful Ally. N.Y. TIMES. June 29, 2004.
49. Buckley, supra note, at 315 (discussing sleep as a biological necessity); see generally Ravelingien &
Sandberg, Sleep better than medicine? Ethical issues related to "Wake Enhancement, " 34 J. MED ETHICS 9
(2008), (discussing how sleep and downtime creates balance in society.)
50. Stoller et al., supra note 25, at 2.
51. Sleep deprivation also interferes with physicians' personal relationships and poses safety concerns
such as the inability to drive home from a shift when a physician is overly exhausted. See Stoller, supra
note 25, at 1; Eric Olson et al., Sleep Deprivation, Physician Performance, and Patient Safety, 136 CHEST
1389, 1394 (2009).
52. Counter Fatigue Guide, supra note 6, at 3.
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performance, and mood.13 More specifically, studies show that continual
sleep deprivation correlates with a profound decrease in ability to navigate
motor and cognitive tasks, such as manual dexterity, reaction time, and
recall tasks.54 Sleep deprived residents report mood disturbances such as
more sadness, more anxiety, less egotism, and less social affection and
more psychophysiologic abnormalities than rested residents."
Importantly, these disturbances in mood also produced difficulty thinking
and confusion, which directly affects residents' ability to perform various
functions of the job from translating knowledge into practice and
integrating knowledge, to effectively diagnosing and communicating with
the patient.56 Additionally, sleep deprivation results in an undesirable and
unprofessional attitude toward colleagues and patients, which undermines
the trust and care of the physician patient interaction.
Sleep also serves as an important regenerative and protective
mechanism to the neurological and physiological systems. During REM
sleep the brain allows neuroreceptors to rest and themselves."
Withholding REM's restorative functions could adversely affect cognition
and mood. 5 9 Non-REM sleep also serves an important function of
sustaining a period of low metabolic demand on the brain and allows the
brain's energy stores to replenish.60 Eliminating periods of non-REM
sleep interferes with the brain's plasticity and ability to support cognitive
tasks.6 1 Research also shows individuals who are chronically sleep
deprived are at risk for further health problems such as increased risk of
morbidity and mortality, hypertension, and compromised immune
systems.62 As science currently stands, no drug or other intervention can
produce the same restorative functions as sleep to the body's neurological
and physiological systems.
The negative effects of sleep deprivation are imperative to consider
given the amount of residents who are sleep deprived. A study conducted
by Stoller and colleagues to assess resident sleep patterns and impact of
these patterns found high levels of sleep loss and fatigue among

53.
54.
55.
56.
57.
58.
59.
60.
6!.
62.

Stoller et al., supra note 25, at 1.
Patton et al., supra note 39, at 6.
Id at 5.
Id.
Idat 7.
Walter Glannon, Pyschopharmacological Enhancement, I NEUROETHICS 45, 47 (2008).
Id.
Id
Id.
Id.
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residents.63 Wile fifteen percent scored in the "mild sleepiness" range,
eighty four percent of residents scored in a range where clinical
intervention is typically indicated.6 4 Not surprisingly, only one percent of
residents scored in a desirable range." This level of sleep deprivation
among an overwhelming majority of resident physicians means they are
experiencing the corresponding negative neurological and physiological
effects of forgoing adequate sleep."

C. Sleep Deprivation And Patient Safety
This overwhelming majority of resident physicians who experience
sleep loss not only encounter personal health issues, but the effects of their
sleep deprivation impacts patient care and safety.67 As discussed above,
sleep is necessary to replenish the brain to learn new information and
skills. 68 Residency is designed to teach physicians complex and multifaceted skills that they did not learn during the medical school program,
which requires residents to be engaged and able to process and retain new
information.6 9 Learning new and specialized tasks is dependent on sleep to
integrate this knowledge and subsequently recall these skills." Thus, sleep
deprived residents are less able to integrate the knowledge they are
learning during their shifts and may be less likely to remember this
information when interacting with future patients.
Numerous studies have examined the impact of physician fatigue on
patient care, finding increased errors and other negative effects on the
In one study, eighty one percent of
physician patient interaction."
residents admitted that sleep has negatively affected their patient care in
some manner." In another study, when medical errors were compiled,
The
forty one percent of physicians attributed the error to exhaustion.

63. Stoller et al., supra note 25, at 3.
64. Id.
65. Id.
66. Many scholars have compared resident physician schedules to other professions such as pilots and
truck drivers where federal regulation places limits on working hours as a measure for public safety. See
Patton et al., supra note 39, at 7.
67. Olson et al., supranote 51, at 1391.
68. Bhavin Sheth et al., Practice Makes Imperfect: Restorative Effects of Sleep on Motor Learning. 3
PLoS ONE e3190 (2008); Glannon, supra note 62, at 47.
69. Whetsell supra note 24, at 25-28.
70. Sheth et al., supra note 68, at e3120.
71. See Whetsell, supra note 24, at 31; Buckley, supra note 41, at 315; Patton et al., supra note 49, at 7;
Olson et al., supra note 51, at 1391.
72. Buckley, supra note 41, at 315.
73. Id.
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California Board of Medical Quality Assurance conducted a study that
showed in seventy five percent of cases, physicians reported knowledge of
a negative impact on patient care arising from long work shifts.74 Even if
physicians do not commit an error, they may not be providing optimal care
for patients if they fail to notice patient symptoms or issues they would
have seen had they been more rested." Other residents have reported such
extreme exhaustion that they literally fall asleep onto their patients during
their shift. 76 Thus, sleep deprivation has a direct and striking correlation
to suboptimal physician patient interactions or medical error.
Compounding these startling admissions is emerging evidence
relating to physician self-assessment of professional abilities despite sleep
deprivation. Despite this level of error related to fatigue, Stoller and
colleagues found some residents believe they develop a tolerance for sleep
deprivation or that they can still perform their duties if they only "fight"
sleep hard enough."
This overconfidence in ability despite sleep
deprivation is unsupported by any evidence, and the statistics above
suggest the contrary- that sleep deprivation endangers both the physician
and the patient especially if the physician cannot accurately gauge her own
limitations of practice arising from fatigue."
IV. WHY MODAFINIL IS NOT A SOLUTION TO PHYSICIAN
FATIGUE

Both scholars and physicians have suggested that residents should
use the stimulant modafinil as a solution to overcome fatigue and prevent
medical error." However, suggesting or advocating that physicians use
modafinil to forgo sleep and mitigate the effects of sleep deprivation from
impairing the physician's physiological and cognitive state ignores the
importance of sleep rather than a substitute and fails to consider the legal
and ethical appropriateness of prescribing federally regulated stimulant
drug for enhancement. To address why physicians using stimulants such
as modafinil is neither a safe nor appropriate answer to the problem of
physician fatigue, this section will describe modafinil, how it is federally
regulated, and provide studies showing the drug's intended and unintended
effects. This section will explain why individual physicians, employers, or
74.
75.
76.
77.
78.
79.

Whetsell, supra note 24, at 31.
Id..
Id.
Stoller et al., supra note 25, at 8.
Id.
Rose & Curry, supra note 16, at 301-302; Webb et al., supra note 19.
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physician associations should not adopt a practice of using modafinil for
PESA based on the high potential for deleterious effects to the physician
and patients.
A. Modafinil's Drug Profile
The FDA approved modafinil to improve wakefulness in adult
patients with excessive sleepiness associated with sleep apnea, shift work
sleep disorder, and narcolepsy." The FDA has not approved modafinil for
additional indications and specifically declined to expand approval to treat
fatigue , so physicians prescribing modafinil to patients for other
conditions occurs off-label. The exact mechanism of how modafinil works
is unclear, but is believed to work selectively through the sleep/wake
centers of the brain to activate the cerebral cortex, which is essential for
wakefulness."' Studies have shown modafinil serves as a countermeasure
for sleep loss and sustains continued wakefulness improve attention,
alertness, spatial planning, and visual pattern recognition memory.82
Clinical trials show modafinil carries risk of producing both minor
side effects such as headaches, nausea, and nervousness, as well as serious
side effects such as rashes including Stevens-Johnson syndrome or a host
of psychiatric symptoms such as mania, delusions, hallucinations,
aggression, and suicidal ideation." Other studies show negative side
effects related to mood and behavior, including experiences of aggression
and irritability.84
However, modafinil is not indicated for use by healthy individuals
and the manufacturer, Cephalon, has specifically addressed patients using
modafinil for PESA purposes." In 2003, an article in the Residency
Program Director's Alert suggested modafinil may provide a solution to
80.

Provigil

package

labeling,

FOOD

AND

DRUG

ADMINISTRATION,

available

at:

http://www.accessdata.fda.gov/drugsatfda docs/label/2007/020717s020s013s0181bl.pdf.
81. Media
Fact
Sheet:
Provigil,
Cephalon,
available
at:
http://www.cephalon.com/fileadmin/media/downloads/PROVIGILFact Sheet.pdf; de Jongh et al., supra
note 4, at 762.
82. de Jongh et al., supra note I , at 763.
83.

Provigilpackage labeling. , FOOD AND DRUG ADMINISTRATION, 12-15 (Aug. 17,2007), available at:

http://www.accessdata.fda.gov/drugsatfda docs/label/2007/020717s020s013s018lbl.pdf.
84. See Douglas Kim, Modafinil: The Journey to Promoting Vigilance and its Consideration by the
Military in Sustaining Alertness, HARV. L. SCHOOL LEGAL ELECTRONIC DOCUMENT ARCHIVE, available
at: http://leda.law.harvard.edulleda/data/826/Kim_07.html.
85. Provigil package labeling, FOOD AND DRUG ADMINISTRATION, 11-12 (Aug. 17, 2007), available at:
Cephalon
http://www.accessdata.fda.gov/drugsatfda docs/label/2007/020717s020s013s018lbl.pdf;
Response to JAMA Article, The Effects of Modafinil on Dopamine and Dopamine Transportersin the Male
Human Brain, CELPHALON (Mar. 2009), available at: http://www.cephalon.com/media/jama-article-theeffects-of-modafinil-on-dopamine.html.
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address resident physician's long and irregular schedules.86 Responses
from residency program directors poured in, and one director asserted,
"There is no role for modafinil use by resident physicians. It is unethical
and irresponsible for physicians to use a stimulant drug while performing
duties related to patient care."" A Cephalon representative responded by
deferring to FDA approved indications, stating that modafinil is a
Schedule IV prescription drug and not intended for use in helping residents
work longer hours, nor is the drug intended to help healthy people forgo
sleep."" Despite this statement, in 2006 and in 2007 Cephalon attempted
to broaden the market for modafinil by disseminating advertising material
expanding the drug's use indication by directing physicians to consider
modafinil when patients present with complaints of tiredness, decreased
activity, or lack of energy.89 Whether intentional or not, this statement
implicitly suggested physicians should prescribe modafinil to generally
boost wakefulness, which may be construed to encompass physicians
prescribing modafinil to other physicians who present with fatigue because
of too many hours on duty.
B. Federal Regulation of Modafinil Under the Controlled
Substances Act
Under federal regulations set forth in the Controlled Substances Act,
modafinil is classified as a Schedule IV controlled substance, which means
it carries a potential for abuse, the drug has an accepted medical use, and
abuse of the drug may lead to physical or psychological dependence." 21
USC§ 829(c) dictates that a practitioner may only dispense Schedule IV
substances to a patient by a valid prescription. 9' Section § 1364.04 sets
forth a two prong requirement that for a prescription to be valid, a
practitioner must issue it (1) for a legitimate medical purpose (2) in the
course of professional practice. 92 I have argued elsewhere that the strict
requirements set forth in the Controlled Substances Act limits physicians'
86. Kelli Westcott, Modafinil, Sleep Deprivation, and Cognitive Functioning in Military and Medical
Settings, 170 MILITARY MED. 333, 335 (2005).
87. Id.
88. Id..
89. Id.
90.

Provigil package labeling, FOOD AND DRUG ADMINISTRATION,

29 (Aug. 17, 2007), available at

http://www.accessdata.fda.gov/drugsatfda-docs/label/2007/020717s020s013s0181bl.pdf;
(b)(4).

91.

21

USC

§812

21 USC §829(c).

92. 21 USC §829. The statute does provide an exception where a practitioner other than a pharmacist
may directly dispense the drug in a circumstance such as where the practitioner provides the patient a
sample size drug during the office visit.
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discretion to legally prescribe a controlled substance such as modafinil for
PESA purposes. That is, "prescribing modafinil for PESA constitutes
neither a legitimate medical purpose nor is prescribing PCEDs within the
defined course of professional practice for physicians."93
Modafinil's regulatory classification means that the legality of
prescribing controlled substances such as modafinil for enhancement
purposes is far from established or accepted and cannot be assumed. " If a
physician chooses to expand the confines of practice and prescribe
modafinil to another physician, the prescribing physician gambles with
potentially facing sanction by the state medical licensing board or even
Controlled substance regulation recognizes the
criminal penalty.95
drug use/abuse has on both the individual
that
prescription
potential
arising from dependency as well as the potential for public harm to
society.96 Growing literature on studies examining the effects of modafinil
further illuminates the reason for strictly regulated prescribing modafinil
and adhering to stringent criteria for a valid prescription."

C. Effects of Using Modafinil
In 2010, Repantis and colleagues published a comprehensive review
of the effects of using modafinil that examined the following outcomes:
mood, wakefulness, motivation, attention, concentration, memory,
learning and executive functions." Several studies in the review showed
that modafinil improved motivation, enhanced performance for particular
tasks, and improved memory on particular tasks.99 In addition to these
desirable effects, some studies demonstrated subjects experienced a sense
93. See Katherine Drabiak-Syed, Reining In The Pharmacological Enhancement Train: We Should
Remain Vigilant About Regulatory Standards For Prescribing Controlled Substances, under review for
publication.
94. The Ethics, Law, and Humanities Committee of the American Academy of Neurology assumes
prescribing of drugs for neuroenhancement is legally permissible, but does not explain its conclusion.
Additionally, the Committee states that the medical principles for prescribing medications for treatment are
the same as for enhancement, but this ignores the goals and guidelines within the purpose of medicine. See
Dan Larriviere et al., Responding to Requests From Adult Patientsfor Neuroenhancements: Guidance of
the Law, Ethics, and Humanities Committee, 73 NEUROLOGY 1406, 1408-1410 (2009).
95. See Drabiak-Syed, supra note 93 (discussing sanction by state medical board or criminal violation of
the Controlled Substances Act for prescribing modafinil for PESA).
96. Panelists Normal Miller et al., Controlled Substance Laws; Are They Meeting the Health Needs of the
Public?, 7 MICH. ST. J. MED. & LAW 81, 82 (2003).
97. See Drabiak-Syed, supra note 93 (discussing elements required for a valid prescription of a controlled
substance).
98. Dimitris Repantis et al., Modafinil And Methylphenidate For Neuroenhancement In Health
Individuals:A Systematic Review, 62 PHARMACOLOGICAL RESEARCH 187 (2010).

99. See id. Sustaining performance over time constitutes an enhancement as the subject becomes fatigued
because the subject's performance would decrease absent any drug intervention.
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of elation, or a high feeling, even to the point of being "overalert."oo
Other studies in the Repantis and colleagues review demonstrated negative
effects on subjects. Some subjects felt increased anxiety or aggression and
in one particular study, subjects reported experiencing both elation as well
as anxiety. o'Repantis and colleagues also found studies that demonstrated
pertinent negative effects, such as decreasing subjects' amount and
accuracy of speech and communication.' 02 These studies show some
subjects may experience the intended drug effects of feeling vigilant and
increasing cognitive functioning, some may not, and some may experience
the intended effect along with undesirable and even counterintuitive
effects such as anxiety or inability to communicate.
In addition to research on how modafinil affects rested, healthy
individuals, Repantis and colleagues separately reviewed studies that
specifically tested modafinil on sleep deprived subjects. This additional
research echoed some of the results above, but established several
pertinent differences for how sleep deprived individuals respond to
modafinil. Although some studies showed modafinil decreased fatigue
and enhanced attention or memory, other studies showed that modafinil
reduced subjective fatigue, but had no effect on attention or memory,
which declined over time according to the subject's level of fatigue. These
studies also showed that modafinil's efficacy can be tied to the time of day
subjects are participating in the study and that modafinil may be less
effective at night.'
Other studies demonstrated modafinil was only
effective with a particular dose, or that its efficacy lasted only a short
time.'"
Repantis and colleagues surmised that for some subjects,
modafinil may have cognitive enhancing effects for the first dose after a
period of moderate sleep deprivation.' However, as the subject becomes
more and more fatigued either from acute or chronic sleep deprivation, the
modafinil will work to sustain the subject's sense of vigilance, but it will
no longer produce the cognitive enhancing effects.'
Compiling multiple studies and finding studies that tested the drug on
sleep deprived subjects shows both unexpected results and how the drug's
effects change depending on the subject's level of fatigue, which are
central to considering how the drug would potentially affect physicians. If
100.
101.
102.
103.
104.
105.

Repantis et al., supra note 98.
Id.
Id.
Id.
Id
Id. at 204.

106.

Id
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a physician takes modafinil as a measure to ward off future fatigue, she
may experience an emotional high, become anxious, or experience
communication difficulties that could interfere with her ability to assess
the patient's needs, interact with the patient to communicate a course of
action, and relay this information to the care team. If a physician takes
modafinil once he is fatigued, he may find it promotes his sense of being
alert, but he cannot remember information from a particular rotation to
accurately place this patient's symptoms or physically fumbles when
More problematically, the fatigued
attempting to suture a wound.
physician may not recognize the decreasing efficacy of the drug on his
physiological and cognitive abilities and fail to see his own impairment.

D. Differential drug responses and unpredictable effects on
physicians
These results as a whole showed that modafinil can enhance or
improve motivation, performance, or memory, but these effects may only
apply to particular individuals, only pertain to particular tasks, or the drug
may not produce this effect at all in individuals who are sleep deprived.
In other words, sleep deprived residents who take modafinil may
experience a sense of vigilance or decreased fatigue, but their cognitive
functioning may still decline as they become more and more sleep
deprived. If the physician expects an increase in cognitive functioning and
does not experience this result, the physician may attempt to remedy the
result by escalating the dose, which could produce a different set of
negative effects and side effects altogether."o7 Notably, the studies also
show modafinil can produce unintended effects such as anxiety,
aggression, or decreased ability to communicate, each of which undermine
how a resident would approach and interact with patients and other
physicians.
The differences in how subjects responded to modafinil and whether
they exhibited the intended effects are also significant. Repantis and
colleagues review showed modafinil works in varying degrees. Different
individuals may experience its effects in a vastly different manner, and it
may only be effective for particular tasks or situations.
Different
individuals may be more susceptible to experiencing negative effects of
the drug either in addition to, or instead, of experiencing the intended
effects.'"
Some research also suggests a vastly different individual
107.
108.

Kim, supra note 84, at 22.
Alain Buguet, Modafinil- Medical Considerationsfor Use in Sustained Operations,74 AVIATION,
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reaction based on dosage as well as individual reaction to a particular
dosage.'09 In one study, subjects who took higher doses of modafinil
experienced jitteriness, shaking, headaches, and hallucinations."o As
pharmacist Danielle Turner noted, the effects of modafinil are neither
These differences are central to
homogenized nor predictable."'
considering the accuracy to which we can predict how individuals will
react to taking modafinil, whether physicians would in fact experience the
noted "positive" effects of the drug, or whether physicians would
encounter negative outcomes relating to affect, mood, or physiological
side effects.
Accordingly, some physicians who take the drug with the expectation
of increasing cognitive functioning during periods of fatigue may find that
the fatigue dissipates so they no longer fall asleep literally on their
patients, but they do not have the ability to process the patient's symptoms
and consider the appropriate course of action because their mind cannot
focus. Furthermore, different individual responses to the drug can produce
significant negative effects that would undermine the physician's ability to
perform duties required for optimal interaction between the physician and
the patient as well as the physician and the hospital staff. The physician
taking modafinil could become aggressive toward the patient, undermining
trust in the physician-patient relationship or become unyielding toward
other hospital staff, straining employee relations. In another scenario, if
the physician experiences impaired communication or anxiety, this may
also lessen the physician's ability to form a positive relationship with the
patient and understand all relevant symptoms or concerns may decrease
and the physician may be unable to effectively relate this information to
the rest of the care team. Studies cannot fully capture distinct individual
response to the drug, especially when a physician uses the drug when he is
experiencing real fatigue and is attempting to interact with a real patient or
perform meticulous tasks such as assisting in a surgery. Furthermore, the
controlled conditions of these studies cannot adequately predict how the
drug would affect real sleep deprived physicians navigating the real
demands of challenging patient cases.'12
SPACE, AND ENVTL. MED. 659, 662 (2003).

109. Id.
110. Id at 661.
I11. Danielle Turner, Cognitive Enhancement in the Pharmacy, 280 THE PHARMACEUTICAL J. 691, 692
(2008).
112. Kim, supra note 84, at 21, 23, 27 (discussing operational applicability); Eric Racine & Cynthia
Forlini, Expectations Regarding Cognitive Enhancement Create Substantial Challenges, 35 J. OF MED.
ETHICS 469 at 469 (2009) (discussing how published studies do not account for the complexity and
diversity of activities in thinking and learning.)
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E. Unintended Problematic Effects of Modafinil Use
1. Overconfidence
Numerous studies found an unintended but significant effect on
subjects' self-monitoring and self-assessment." 1
These studies
demonstrated subjects misjudged their level of impairment arising from
fatigue and ability to perform various study tasks, and that subjects were
overconfident in projecting their own abilities.l 4 Within two hours of
ingesting modafinil, subjects rated their ability to perform various
cognitive tasks as higher than their actual ability performing study tasks."
One study noted this becomes problematic because if the subject taking the
drug experiences the subjective effects differently than the overt
performance, then this increases the potential for human error."' This
finding becomes even more troubling when taken together with Stoller and
colleagues observation that some physicians believe they adapt to less
sleep and retain the same cognitive abilities."' In practice, this could
mean that a group of physicians forgo taking modafinil because they
believe despite their fatigue, their cognitive abilities are intact. The second
group who uses modafinil over a period of time builds more and more
sleep debt and believes that the drug increases their cognitive abilities,
when in fact their minds become more and more exhausted and they are
objectively unable to perform at the level at which they believe they are
performing.
If a physician takes modafinil with the expectation of increasing
cognitive ability during a period of sleep deprivation on a long shift, then
the physician may believe he is able to think through all possible
diagnoses for the new patient or that he is able to perform a complex
surgery, when in fact his cognitive ability and physiological abilities have
decreased dramatically from his state of fatigue. This poses numerous
problems beyond the obvious of the physician providing inefficient and
possibly dangerous care, but it also raises the concern of self-assessment
and external assessment of the physician's care by the rest of the care
team.

113.
114.
115.
116.
117.

Buguet, supra note 108, at 662; Kim, supra note 84, at 19; Repantis et al., supra note 98, at 204.
Kim, supra note 84, at 19.
Buguet, supra note 108, at 662.
Kim, supranote 84, at 19.
Stoller et al., supra note 25, at 2.
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2. Potential for Abuse and Dependence
Initial research and Cephalon's marketing material claimed that
modafinil carried a "superb safety profile" and functioned differently than
existing stimulants because it did not affect dopamine in the brain or pose
risk of addiction."' However, post-market surveillance revealed modafinil
does implicate dopamine by blocking dopamine transporters in the brain,
which increases the amount dopamine in the brain." 9 This means despite
original assertions relating to the drug's safety profile, individuals using
the drug do in fact face the potential for drug dependency and addiction.'2 0
Repantis and colleagues' review also found that in several studies subjects
reported experiencing the "good drug" effects of a stimulant drug, marked
by a feeling of elation or "high" in some subjects or at certain dosages.12
The federal regulatory classification of modafinil as a Schedule IV
controlled substance explicitly recognizes that modafinil poses risk of
abuse and addiction to individuals using the drug. 122 Modafinil's potential
to induce addiction is also significant as it means physiological or
psychological dependency on the drug may undermine the individual's
autonomous decision-making capacity to weigh the risks and benefits
related to continued use of modafinil.123
The potential for abuse or dependence has serious implications for
physicians who may use the drug because they think they cannot work a
long shift without modafinil and become psychologically dependent on
using it. Even if a physician experiences the intended effects of increased
vigilance and cognitive abilities during the first few uses of the drug, the
physician may attempt to forgo sleep for long periods of time or sustain a
schedule with only a few hours of sleep and eventually the drug's potential
for cognitive enhancement will likely decrease. The physician then may
continue taking the drug believing this to be the only way to work the
required shifts, or begin taking higher doses to compensate to the
diminishing effects. Alternatively, and more troubling, the physician may
continue taking a steady dose of modafinil but she may not be able to
118. Westcott, supra note 86, at 334.
119. Nora Volkow, et al., Effects of Modafinil on Dopamine and Dopamine Transporters in the Male
Human Brain, 301 J.OF THE AM. MED. ASS'N. 148 (2009).
120. Id.; Heidi Ledford, Cognitive Enhancement Drug May Also Cause Addition, NATURE NEWS,
available at: http://www.nature.com/news/2009/090317/full/news.2009.170.html.
121. Repantis et al., supra note 98, at 194-201.
at
available
DRUG
ADMINISTRATION,
FOOD
AND
package
labeling,
122. Provigil
21 USC§ 812
http://www.accessdata.fda.gov/drugsatfda-does/label/2007/020717s020s013s0181bl.pdf;
(b)(4) (2006).
123. Larriviere et al., supra note 94, at 1410.
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accurately assess a growing decline in her professional skills if she
subjectively feels alert. That is, a physician may continue to use modafinil
based on perceived need or as a mechanism to feel alert on each shift and
the normal response of fatigue to inform the physician that his body and
brain need rest becomes muted. This scenario raises cause for concern
because the physician is still sleep deprived, the physician's fatigue is
negatively affecting patient care and the physician's interaction with the
rest of the care team, but now the physician's does not recognize that these
potential problems are arising from sleep deprivation and continued use of
modafinil.
V. MODAFINIL (MIS)USE AND PHYSICIAN IMPAIRMENT
DEFINED BY STATE LAW
The unpredictability of how physicians would react to modafinil
along with the danger that using modafinil poses to physicians and patients
means modafinil constitutes an ill-advised solution from a pragmatic
perspective. In addition to these concerns, if a physician uses modafinil
while on duty, this implicates a prohibition against practicing medicine
while using or under the influence of non-medical drugs. This section will
describe how a physician using modafinil during a shift violates the
physician's ethical and legal duties governing the medical profession.
Importantly, violation of these duties can result in professional sanction to
the physician or expose the physician and hospital to medical malpractice
liability.
A. Use, Misuse, Abuse, and Dependence
When a physician takes a prescription controlled substance for a nonmedical reason for enhancement, this practice can range from occasional
use to dependency and addiction. Unlike taking a prescription controlled
substance for a legitimate medical purpose, federal regulatory agencies do
not recognize a permissible "use" of stimulant drugs for enhancement
purposes.'2 4
If physicians use modafinil for PESA, this "use" can be considered
misuse or abuse.'25 The Substance Abuse and Mental Health Services
Administration (SAMHSA) defines the use of prescription drugs for a
124. PrescriptionMedications: Misuse, Abuse, Dependence, and Addiction, Substance Abuse Treatment
Advisory, Substance Abuse and Mental Health Services Administration, available at:
http://www.kap.samhsa.gov/products/manuals/advisory/pdfs/Prescription-Meds.pdf
125. Id.
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non-medical reason as using the drug for the experience that the drug
causes.12 6 SAMHSA clarifies these non-medical reasons include using a
drug to stay awake, increase focus, or increase attention.'27 According to
these definitions, a physician who obtains a prescription and uses
modafinil to forgo sleep during a long shift or to increase waning
concentration is using modafinil for a non-medical reason. The National
Institute on Drug Abuse (NIDA) equates non-medical use of prescription
drug use, to prescription drug abuse.' 28 This includes the use of modafinil
for cognitive enhancement purposes. Thus, according to SAMSHA and
NIDA's definitions, physician use of modafinil for PESA constitutes
misuse and abuse of the drug. These definitions are significant because
they reiterate that the military's erasure of removing the line between
maintenance and enhancement cannot apply to how we classify civilian
use of modafinil. This is especially salient in a closely regulated
profession such as physicians.
Physician use of modafinil for PESA may also rise to the level of
dependency and addiction. The Diagnostic and Statistical Manual IV
defines substance dependence as a "maladaptive pattern of substance use
leading to clinically significant impairment or distress" and sets forth a list
of criteria that signify addiction.'29 Physicians may be especially prone to
substance abuse as a means to alleviate the high stress of the profession
and their ability to access a supply of drugs.'30 Even if physician use of
modafinil for PESA does not rise to the level of dependency, SAMSHA's
and NIDA's classifications that non-medical use of the drug for
enhancement constitutes misuse or abuse is significant because it
delineates how to approach a physician's ethical and legal duties of
practicing medicine.
B. Physicians' Ethical Duty to Refrain From Substance Use/Abuse
Standards governing the practice of medicine recognize the link
between physicians' level of well-being (or impairment) and the quality of
126. Id
127. Prescription Drug Abuse in the Workplace, Substance Abuse and Mental Health Services
Administration, I (Nov. 29, 2010), http://www.workplace.samhsa.gov/Workplaces/pdf/Prescription%
20Drug%2OAbuse%20Fact%2OSheet.pdf.
128. National Institute of Drug Abuse, Definition-for Prescription Drug Abuse (Nov. 23, 2010), MedLine
Plus, available at: http://www.nlm.nih.gov/medlineplus/prescriptiondrugabuse.html.
129. AMERICAN PSYCHIATRIC ASSOCIATION. DIAGNOSTIC AND STATISTICAL MANUAL IV OF MENTAL
DISORDERS. (2000).

130. Prescription Drug Abuse in the Workplace, Substance Abuse and Mental Health Services
Administration, I (Nov. 29, 2010) http://www.workplace.samhsa.gov/Workplaces/pdf/Prescription%20
Drug%20Abuse%2OFact%2OSheet.pdf.
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care a physician can provide to patients. As in other professions such as
public carriers or police officers, physicians and patients fall into the legal
category of a "special relationship" that implicates public health and
safety.13 ' These other "special relationship" professions set forth explicit
limits on work hours and prohibit substance abuse during shifts in
recognition that a person's performance of the occupation is particularly
susceptible to decreased physiological and cognitive functioning arising
from fatigue or substance abuse. 132 Furthermore, physicians must perform
technical tasks using specialized skills and exercise professional judgment
relating to diagnosis and treatment options, which constitutes what some
scholars have classified as safety-sensitive work."' That is, patient care
involves such a high risk of injury from even a momentary lapse of
attention or judgment that professional guidelines governing the medical
profession explicitly prohibit substance abuse during a shift.' 34
The American Medical Association's (AMA) Office of General
Counsel recognizes the immense responsibility that physicians must
uphold in caring for patients and the effect that physician substance abuse
can have on the physician's ability to perform duties and deliver optimal
care to the patient."' The Office of General Counsel has stated, "When
physicians or other individuals who are employed to protect the health and
safety of the public abuse drugs, the consequences are potentially life
threatening. . . [W]hile there are no good data in the extent to which drug
abuse by physicians results in substandard patient care, even a small risk
cannot be tolerated. The harm to a patient from an impaired physician can
be life threatening."' 3 6 The AMA articulated this position in Opinion 8.15
regarding substance abuse, which unequivocally states that it is unethical
for a physician to practice medicine while under the influence of a
controlled substance, alcohol, or other chemical agents that impair the
ability to practice medicine."
Applying SAMSHA's and NIDA's definitions, a physician using
modafinil for PESA during a shift equates to a physician abusing
modafinil during a shift. As discussed in Section IV, a physician's use of
131. Dana Devon, Drug Testing of Health Care Workers: Toward a Coherent Hospital Policy, 23 AM. J.
L. AND MED. 399, 415 (1997).
132. See Patton et al., supranote 39, at 20.
133. Devon, supra note 130, at 407.
134. Id.
135. Devon, supra note 131, at 406.
136. Id. at 407.
137. American Medical Association, Opinion 8.15 Substance Abuse (Nov. 29, 2010), available at:
http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medicalethics/opinion815.shtml.
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modafinil for PESA during a shift poses a risk to the physician arising
from numerous unintended effects and side effects that would
unpredictably affect the physician's performance, judgment, and patient
care abilities. Permitting or endorsing physician use of modafinil knowing
these attendant risks to patients is incompatible with the AMA's stance

and express prohibition against practicing medicine under the influence of
a controlled substance. As the Council on Ethical and Judicial Affairs
aptly noted, when a physician's health is compromised, so too is the
patient's.'
C. Physicians Legal Duty to Refrain From Substance Use/Abuse
State legislatures recognize the link between physician impairment,
the ability to effectively practice medicine, and the resulting effects on
patient care. To monitor physicians' ability to practice medicine, state law

sets forth two complementary statutory sections. First, state law contains
specific prohibitions against practicing medicine while impaired or
practicing while under the influence of drugs. Second, state statutes task
the respective state medical boards with the duty of protecting patients, the

obligation to investigate allegations of impaired physicians, and the
authority to respond appropriately with treatment or professional
sanction.'3 9 To understand how state law approaches a physician using
modafinil, this subsection will describe how three different states define
impairment and what actions these states may take to address an impaired

physician.
1. Professional Misconduct and Physician Impairment
States statutes vary with respect to how each legislature defines
professional misconduct arising from physician impairment or a decline in
the ability to effectively practice medicine. 4 0

New York defines professional misconduct as "practicing the
profession while the ability to practice is impaired by alcohol, drugs,

physical disability, or mental disability" or "being habitually drunk or
being dependent on, or a habitual user of narcotics, barbiturates,

138. See Physician Health and Weliness, Report on the Council on Ethicaland JudicialAffairs 5- 1-03, 2,
available at: http://www.ama-assn.org/amal/pub/upload/mm/code-medical-ethics/9031b.pdf (last visited
Nov. 29, 2010).
139. See Phyllis Coleman & Ronald Shellow, Restricting Medical Licenses Based on Illness is WrongReporting Makes it Worse, 9 J. L. & HEALTH 273, 281-282 (1994/1995).
140. The following state law discussion is only a small example of how some states define impairment.
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amphetamines, hallucinogens, or other drugs having similar effects."'
The first clause can be interpreted to mean that a physician using a
controlled substance with the ability to change the physician's judgment,
affect, and skills constitutes practicing while impaired. The second
clause's non-inclusive listing means that modafinil would likely also fall
into the category of these drugs because like the other listed drugs,
modafinil is regulated as a controlled substance. Further, modafinil is
classified within the subcategory of stimulant drugs along with
amphetamines and would have similar intended enhancement effects.
Using modafinil in a habitual manner refers to a range of use frequency,
either from using every shift to turning to modafinil as the solution when
the physician seeks to forgo sleep and obtain a cognitive functioning
boost. By listing several examples of professional misconduct, the
legislature unequivocally seeks to classify practicing medicine in a
condition that would pose a danger to patients or undermine the
physician's professional skills and judgment as professional misconduct.'42
Similar to New York, Michigan's statute refers to the concept of
impairment and the relationship of a physician's substance use. Michigan
states that "impaired or impairment means the inability or immediate
impending inability of a health professional to practice his or her health
profession in a manner that conforms to the minimum standards of
acceptable and prevailing practice for that health profession due the health
professional's substance abuse, chemical dependency, or mental illness or
the health professional's use of drugs or alcohol that does not constitute
substance abuse or chemical dependency."' 4 3 According to the plain
meaning of the statute, one possible interpretation infers that a physician's
use of modafinil equates to an inability to practice medicine in a manner
that conforms to the prevailing practice because using stimulants for PESA
during a shift is not the current prevailing practice. Even without this
assumption, this definition recognizes that the mere use of a substance
even if it does not rise to dependency can compromise the physician's
professional ability to practice medicine. The standard of practice set forth
by the AMA reiterates that physician use of substances during a shift
imposes a potentially grave risk of harm to patients.1' Accordingly, under
New York's law mere use modafinil during a shift would constitute a state
of impairment.
141.
142.
143.
144.

N.Y. EDUC. LAw§6509 (2010).
N.Y. EDUC. LAW § 6509 (2008).
MICH. COMP. LAWS § 333.16106(a) (2010).
See Devon, supra note, at 406-407.
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On its face, Texas' law appears to set a higher bar for unprofessional
conduct or physician impairment. Texas provides that a violation occurs
when the physician "is unable to practice medicine with reasonable skill
and safety to patients because of: . .. excessive use of drugs, narcotics,

Despite the qualification of
chemicals, or another substance." 45
"excessive use," which would seem to permit occasional of use substances
such as modafinil during a shift, the statute contains an additional
informative clause. A subsequent section states that a physician who "fails
to practice medicine in an acceptable professional manner consistent with
public health and welfare" commits a professional violation.146 As
discussed in Section IV, studies show modafinil affects individuals in
varied ways, sometimes achieving the desired result of vigilance and
cognitive enhancement, sometimes only sustaining vigilance without
affecting cognition, and, problematically, in some instances undermining
the user's ability to self-assess capabilities and performance.147 These
scientific results indicate that using modafinil constitutes using a substance
that impairs judgment, professional capabilities, performance, and elevates
the risk of medical mistake or injury to the public. Thus, like New York
and Michigan, Texas would likely classify physicians using modafinil
during a shift as a professional violation.
Although states may approach the issue with slightly varied
terminology, these states demonstrate that legislatures recognize the effect
that substance use during a shift has on a physician's professional
capabilities, judgment, and skills. This decline in ability directly
undermines a physician's ethical duties to protect the health and safety of
the patient because it exposes patients to a risk of harm from error or
oversight. Repantis and his colleagues' review showed that a physician
who continues to take modafinil while sleep deprived and building more
and more sleep debt may experience a sense of vigilance, but he may no
longer receive the cognitive boost, and may not be cognizant of his
diminishing cognitive function. The potential for decline in a physician's
ability along with the significant possibility of overconfidence means
using modafinil for PESA would likely impair the physician's ability to
practice medicine.
2. Consequences of Professional Violation and Impairment
Once the state medical board receives allegations of a physician's
145.
146.
147.

TEX. Occ. CODE ANN. § 164.051(4) (2010).
TEX. OCC. CODE ANN. § 164.051(6) (2010).
See generally Repantis et al., supra note 98.
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alleged professional misconduct or impaired practice, the state medical
board may take several courses of action outlined in a corresponding
section of the respective state's statute. New York promulgates penalties
for professional misconduct that range from the rehabilitative end of the
spectrum such as mandated training or courses, to holding a hearing to
suspend or revoke the physician's state license to practice medicine.'
Michigan authorizes the state medical board to conduct an investigation
into the allegations and refer to the appropriate committee to impose
sanction on the alleged offending physician.149 Finally, Texas generally
authorizes the state medical board to take disciplinary action against the
Each of these provisions demonstrate the
offending physician.'
behavior and actions where physicians'
sanction
legislatures' intent to
judgment, capabilities, and performance is compromised and where
potential harm to patients increases. Therefore, if a physician chooses to
use modafinil during a shift, the physician will not only face personal
health risks and expose his or her patient to additional risks, but may also
face the possibility of sanction for committing a professional violation.
In addition to professional sanction, a physician who practices
medicine while impaired or commits a professional violation may face
varied claims under medical malpractice tort liability. For example,
Michigan, specifically states that a physician who practices medicine
while impaired violates a general duty of negligence or a failure to
exercise due care."' Additionally, the hospital that employs the physician
may face liability if it breaches its duty to provide quality medical care to
its patients.'5 2 The potential for individual and corporate liability provides
an additional incentive for the physician to not use modafinil and for the
hospital to prohibit its use while on site.

VI. CONCLUSION
Physicians as a profession are already exposed to ill health effects
arising from long, demanding schedules and sleep deprivation and
exposing physicians and patients to additional risks by permitting or
advocating that physicians simply use a stimulant drug is inappropriate
and problematic. Although the military has creatively redefined the terms
for permitting and endorsing stimulants such as modafinil as a means to
148.
149.
150.

N.Y. EDUC. LAW §6511 (2008).
MICH. COMP. LAWS § 333.16221 (2010).
TEX. OCC. CODE ANN. § 164.051 (2010).
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See MICH. COMP. LAWS

152.

Devon, supra note 130, at 412-419.
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achieve alertness during continuous performance, further research of the
modafinil's effects demonstrate numerous pragmatic, ethical, and legal
concerns of crossing the bridge into civilian use. Modafinil cannot
biologically replace sleep and it does not fix the underlying problem that
physician exhaustion creates for the physician's cognitive, neurological,
and physiological health and its direct correlation to suboptimal patient
care. The FDA has not approved modafinil as a means to generally
increase wakefulness or counteract employer imposed sleep restriction.
Federal regulations set forth in the Controlled Substances Act strictly
control physician prescribing of this stimulant in recognition of its
powerful effects and potential for abuse. Additionally, recent studies
demonstrate both the unpredictability of modafinil's capability to produce
its desired result once the user becomes sleep deprived and the troubling
implications for the user to effectively evaluate performance and ability
under the influence. These differential drug reactions and unintended side
effects are fundamentally incompatible with the safety sensitive medical
profession. Notably, federal agencies recognize that physicians' special
relationship with patients means prohibiting the use of a substance that
could elevate risk of injury to the patient. Furthermore, if physicians
choose to circumvent these ethical duties of practicing medicine,
physicians are still bound by a legal duty to refrain from substance use that
impairs their ability to practice medicine during patient care and may face
professional sanction or tort liability for noncompliance with state law for
using modafinil.

